In response to the COVID-19 Pandemic, Intellipure US conducted a series of tests to show the efficacy of its DFS technology on the capture and elimination of airborne virus and bacteria. World-renowned Infection Control expert and an advisor to the U.S. EPA and the World Health Organization, Dr. Syed Sattar, conducted his studies in a chamber that was built to comply with U.S. EPA guidelines and tests concluded the following:

DFS technology was proven to inactivate a proxy virus for SARS-CoV-2 (RNA virus MS2): The results of this data show, 99.987% elimination in 10 minutes. The test also indicated that there was 100% elimination in 45 minutes and again 100% at 24 hours indicating no regrowth. The bacteriophage MS-2 is a small (about 30 nanometers), a non-enveloped virus, which is often used as a surrogate for small, non-enveloped human pathogenic viruses such as noroviruses.

Testing with Bacteriophage Phi6 as the Challenge-Testing indicated a 99.99% reduction in 10 minutes. Bacteriophage Phi6 is a larger (about 100 nanometers), enve loped virus, which is often used to represent large, enveloped human pathogenic viruses such as coronaviruses and influenza viruses.

– Efficacy of DFS technology on the capture and elimination of SARS-CoV-2 proxy virus that causes COVID19 by world-renowned Infection Control expert and an advisor to the U.S. EPA and the World Health Organization, Dr. Syed Sattar


Purifying the Air of Tomorrow.

Our patented Disinfecting Filtration System (DFS) Technology traps microorganisms for continuous germicidal exposure, resulting in the most powerful indoor air purification in the world. DFS Technology has four times the filter loading capacity than a typical HEPA rated filter , capturing 99.99% of particles at 0.007 microns. This makes HealthWay’s air purification systems the most efficient available.

HEPA: 99.97% efficient at .3 micron
Healthway DFS: 99.99% efficient at 0.007 microns (40x more than a typical HEPA filtration )

HEPA: Limited microorganism capture
Healthway DFS: Captures 99.99% of harmful microorganisms

HEPA: No VOC (volatile organic compound) removal
Healthway DFS: VOC oxidation and adsorption

Origins of ultrafine particles Airborne particles

originate from many natural and man-made sources (e.g. sand dust, fires, diesel smoke, sea salt). Ultrafine particles are only generated at very high temperatures, such as combustion processes, including wood fires, car engines, industry, cooking fumes and cigarette smoke.

Potential health hazards

Ultrafine particles penetrate deep in the lungs. The concentration of these particles is higher, making them harder for the lungs to deal with, leading to inflammation. Also, these particles are small enough to enter the cells in the body and end up in the bloodstream, potentially causing heart and brain diseases. Children, elderly people and people with lung problems like asthma are especially vulnerable to ultrafine particle air pollution.

Global regulations

There are currently no official regulations in place to deal with the ultrafine particle epidemic. But they are in the process of being developed by several regulatory bodies, such as ISO, OECD, EPA and CEN.